Relationship_NN between_IN Antibiotic_JJ Resistance_NN in_IN Streptococcus_NP pneumoniae_NNS and_CC That_DT in_IN Haemophilus_NP influenzae_NP :_: Evidence_NN for_IN Common_JJ Selective_JJ Pressure_NN lactam_NN and_CC trimethoprim-sulfamethoxazole_NN (_( SXT_NN )_) resistance_NN among_IN S._NP pneumoniae_NP and_CC H._NP influenzae_NP (_( ,_, ,_, -_: )_) ,_, which_WDT may_MD be_VB attributed_VBN to_TO differences_NNS in_IN antibiotic_JJ consumption_NN and_CC infection_NN control_NN practices_NNS between_IN countries_NNS ._SENT Interspecies_NN relationships_NNS of_IN resistance_NN prevalence_NN are_VBP not_RB commonly_RB reported_VBN ._SENT During_IN 1999_CD to_TO 2000_CD ,_, 5,015_CD S._NP pneumoniae_NNS and_CC 4,846_CD H._NP influenzae_NP isolates_NNS were_VBD prospectively_RB collected_VBN from_IN hospital_NN laboratories_NNS in_IN China_NP (_( three_CD sites_NNS )_) ,_, Hong_NP Kong_NP (_( two_CD sites_NNS )_) ,_, South_NP Korea_NP (_( four_CD sites_NNS )_) ,_, Thailand_NP (_( four_CD sites_NNS )_) ,_, France_NP (_( nine_CD sites_NNS )_) ,_, Germany_NP (_( eight_CD sites_NNS )_) ,_, Ireland_NP (_( one_CD site_NN )_) ,_, Italy_NP (_( six_CD sites_NNS )_) ,_, Spain_NP (_( six_CD sites_NNS )_) ,_, the_DT United_NP Kingdom_NP (_( seven_CD sites_NNS )_) ,_, South_NP Africa_NP (_( eight_CD sites_NNS )_) ,_, Brazil_NP (_( six_CD sites_NNS )_) ,_, and_CC Mexico_NP (_( five_CD sites_NNS )_) ._SENT Isolates_NNS were_VBD submitted_VBN to_TO Focus_NP Technologies_NPS (_( Herndon_NP ,_, Va._NP )_) for_IN antimicrobial_JJ susceptibility_NN testing_NN by_IN NCCLS_NP broth_NN microdilution_NN using_VBG NCCLS_NP 1999_CD interpretive_JJ criteria_NNS ._SENT Relationships_NNS between_IN the_DT proportion_NN of_IN resistant_JJ isolates_NNS in_IN each_DT country_NN to_TO individual_JJ antimicrobial_JJ agents_NNS were_VBD tested_VBN by_IN measuring_VBG the_DT correlation_NN coefficient_NN (_( r_LS )_) using_VBG a_DT t_NN test_NN analysis_NN ._SENT Antimicrobial_JJ susceptibility_NN of_IN S._NP pneumoniae_NP and_CC H._NP influenzae_NP to_TO all_DT agents_NNS tested_VBN is_VBZ shown_VBN ._SENT Among_IN S._NP pneumoniae_NNS organisms_NNS ,_, considerable_JJ variations_NNS in_IN resistance_NN to_TO beta-lactams_NNS ,_, macrolides_NNS ,_, and_CC SXT_NN were_VBD detected_VBN between_IN countries_NNS ,_, especially_RB in_IN Eastern_JJ regions_NNS of_IN the_DT world_NN ._SENT Levofloxacin_NN resistance_NN by_IN S._NP pneumoniae_NNS was_VBD rare_JJ in_IN most_RBS countries_NNS (_( except_IN China_NP ,_, 3.3_CD %_NN ,_, and_CC Hong_NP Kong_NP ,_, 8.0_CD %_NN )_) and_CC undetected_JJ in_IN H._NP influenzae_NP ._SENT Ampicillin_NN and_CC SXT_NN resistance_NN among_IN H._NP influenzae_NP varied_VBD considerably_RB by_IN country_NN ,_, with_IN high_JJ rates_NNS of_IN resistance_NN detected_VBN in_IN the_DT same_JJ regions_NNS as_IN those_DT with_IN higher_JJR resistance_NN rates_NNS among_IN pneumococci_NNS ._SENT An_DT interspecies_NNS comparison_NN of_IN the_DT proportion_NN of_IN penicillin-resistant_JJ S._NP pneumoniae_NNS and_CC ampicillin-resistant_JJ H._NP influenzae_NP by_IN country_NN demonstrated_VBD a_DT highly_RB significant_JJ relationship_NN (_( r_LS =_SYM 0.928_CD ;_: P_NN <_SYM 0.001_CD )_) ._SENT A_DT significant_JJ interspecific_JJ relationship_NN (_( r_LS =_SYM 0.714_CD ;_: P_NN <_0.01) 0.05_CD )_) were_VBD found_VBN for_IN resistance_NN to_TO amoxicillin-clavulanate_NN ,_, cefuroxime_NN ,_, clarithromycin_NN ,_, or_CC levofloxacin_NN ._SENT The_DT interspecific_JJ relationship_NN observed_VBD for_IN beta-lactam_NN and_CC SXT_NN resistance_NN has_VBZ not_RB been_VBN reported_VBN previously_RB ._SENT beta-Lactam_NN resistance_NN in_IN S._NP pneumoniae_NP and_CC H._NP influenzae_NP is_VBZ conferred_VBN by_IN unrelated_JJ mechanisms_NNS ;_: respectively_RB ,_, penicillin-binding_VBG protein_NN alterations_NNS and_CC expression_NN of_IN TEM-1_NP or_CC ROB-1_NP beta-lactamases_NNS ._SENT S._NP pneumoniae_NNS resistance_NN to_TO SXT_NN is_VBZ chromosome_NN encoded_VBN by_IN mutations_NNS in_IN folA_NN and_CC sulA_NN ._SENT In_IN H._NP influenzae_NP ,_, mutations_NNS in_IN the_DT chromosome-encoded_JJ folH_NN have_VBP been_VBN shown_VBN to_TO encode_VB trimethoprim_NP resistance_NN ,_, while_IN sulfamethoxazole_NN resistance_NN is_VBZ likely_JJ chromosome_NN encoded_VBN through_IN a_DT sulA_NN analogue_NN ._SENT As_IN such_PDT the_DT relationship_NN between_IN resistance_NN in_IN these_DT species_NN suggests_VBZ a_DT response_NN to_TO a_DT common_JJ selective_JJ pressure_NN with_IN increases_NNS in_IN resistance_NN likely_RB driven_VBN independently_RB of_IN each_DT other_JJ ,_, either_CC by_IN acquisition_NN of_IN a_DT resistance_NN mechanism_NN or_CC through_IN clonal_JJ expansion_NN of_IN resistant_JJ isolates_NNS ,_, a_DT phenomenon_NN well_RB documented_VBN in_IN S._NP pneumoniae_NNS but_CC not_RB in_IN H._NP influenzae_NP ._SENT No_DT interspecies_NNS correlation_NN between_IN the_DT incidences_NNS of_IN clarithromycin_NN ,_, cefuroxime_NN ,_, or_CC levofloxacin_NN resistance_NN was_VBD observed_VBN ._SENT These_DT observations_NNS are_VBP presumably_RB despite_IN exposure_NN to_TO the_DT same_JJ antibiotic_JJ selective_JJ pressure_NN ._SENT The_DT relationship_NN between_IN resistance_NN in_IN these_DT species_NN provides_VBZ evidence_NN that_IN antibiotic_JJ usage_NN drives_NNS resistance_NN and_CC suggests_VBZ that_IN attempts_NNS to_TO control_VB the_DT emergence_NN of_IN resistance_NN in_IN S._NP pneumoniae_NNS through_IN prudent_JJ antibiotic_JJ consumption_NN or_CC improved_VBN infection_NN control_NN may_MD impact_VB on_IN resistance_NN prevalence_NN in_IN H._NP influenzae_NP and_CC perhaps_RB other_JJ species_NNS ._SENT Surveillance_NN of_IN antibiotic_JJ consumption_NN and_CC infection_NN control_NN practices_NNS is_VBZ necessary_JJ to_TO further_RBR explore_VB this_DT phenomenon_NN ._SENT (_( This_DT work_NN was_VBD previously_RB presented_VBN in_IN part_NN at_IN the_DT 40th_JJ Interscience_NN Conference_NN on_IN Antimicrobial_JJ Agents_NNS and_CC Chemotherapy_NN ,_, Toronto_NP ,_, Canada_NP [_SYM A._NP M._NP Staples_NP ,_, C._NP Thornsberry_NP ,_, I._NP A._NP Critchley_NP ,_, K._NP S._NP Murfitt_NP ,_, D._NP F._NP Sahm_NP ,_, and_CC M._NP E._NP Jones_NP ,_, Abstr_NP ._SENT 40th_JJ Intersci_NP ._SENT Conf_NP ._SENT Antimicrob_NN ._SENT Agents_NPS Chemother_NP ._SENT ,_, abstr_NP ._SENT C-1221_NP ,_, 2000_CD ]_SYM ._SENT )_) FIG._NN 1_CD ._SENT :_: Incidence_NN of_IN resistance_NN to_TO different_JJ antimicrobials_NNS tested_VBN against_IN S._NP pneumoniae_NNS Incidence_NN of_IN resistance_NN to_TO different_JJ antimicrobials_NNS tested_VBN against_IN S._NP pneumoniae_NP and_CC H._NP influenzae_NP isolates_VBZ by_IN country_NN ,_, utilizing_VBG NCCLS_NP interpretative_JJ criteria_NNS ._SENT In_IN order_NN by_IN country_NN ,_, the_DT numbers_NNS of_IN S._NP pneumoniae_NP and_CC H._NP influenzae_NP isolates_VBZ and_CC the_DT percentage_NN that_WDT was_VBD H._NP influenzae_NP beta-lactamase_NN positive_NN were_VBD as_RB follows_VBZ :_: Brazil_NP (_( 448_CD ,_, 274/10.6_CD %_NN )_) ,_, China_NP (_( 214_CD ,_, 198/10.6_CD %_NN )_) ,_, France_NP (_( 547_CD ,_, 454/5.6_CD %_NN )_) ,_, Germany_NP (_( 560_CD ,_, 639/6.9_CD %_NN )_) ,_, Hong_NP Kong_NP (_( 175_CD ,_, 178/27.5_CD %_NN )_) ,_, Ireland_NP (_( 17_CD ,_, 37/10.8_CD %_NN )_) ,_, Italy_NP (_( 491_CD ,_, 521/10.6_CD %_NN )_) ,_, Mexico_NP (_( 271_CD ,_, 226/17.7_CD %_NN )_) ,_, South_NP Africa_NP (_( 701_CD ,_, 627/7.3_CD %_NN )_) ,_, South_NP Korea_NP (_( 351_CD ,_, 272/60.7_CD %_NN )_) ,_, Spain_NP (_( 492_CD ,_, 559/20.9_CD %_NN )_) ,_, Thailand_NP (_( 206_CD ,_, 305/45.5_CD %_NN )_) ,_, and_CC the_DT United_NP Kingdom_NP (_( 542_CD ,_, 556/11.3_CD %_NN )_) ._SENT 